Children with drug-resistant epilepsy may find relief with the help of medical cannabis oil that contains both CBD and lose dose THC. The oil, which contains 95% CBD and 5% THC, can reduce or prevent epileptic seizures in those with epileptic encephalopathy.
Cannabidiol could help cut seizures by half in children and adults with Lennox-Gastaut syndrome, an extremely severe form of epilepsy, researchers report.
Staphylococcal enterotoxin, a bacterial toxin implicated in some ARDS cases, can be prevented by treatment with the cannabis compound THC. Findings also suggest a potential role for using cannabinoids to treat ARDS caused by COVID-19.
A cannabis derivative reduced seizure frequency by 39% in patients with Dravet syndrome.
Researchers shed light on the endocannabinoid system and report how cannabis is helping to provide relief to many with medical problems.
A two-week course of CBD helps normalize and restore the function of two proteins associated with reducing amyloid-beta accumulation in mouse models of familial Alzheimer's disease. CBD also reduces levels of IL-6, an immune protein associated with inflammation in Alzheimer's patients.
Cannabidiol (CBD) appears to slow the growth of glioblastoma brain cancer cells in both animal and human cell lines. CBD's anti-cancer actions target mitochondria, causing them to dysfunction and release harmful reactive oxygen species. Cancer cells treated with CBD exhibited significant decreases in mitochondrial activity.
Many cannabis users don't know how much THC or CBD is considered an effective dose.
According to researchers, cannabinoids can reduce cravings and help ease withdrawal for those addicted to opioids.
A new study reports cannabidiol, a marijuana derivative, is effective at reducing seizure frequency in children and adults with treatment resistant epilepsy.